Gastroenterology Market By Product Type (Endoscopy Devices, Diagnostic Imaging Systems, Biologics, Surgical Instruments, Endoscopic Ultrasound (EUS) Systems, Laparoscopy Instruments), By Disease Type (Inflammatory Bowel Disease (IBD), Colorectal Cancer, Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Celiac Disease, Peptic Ulcer Disease), By Procedure Type (Diagnostic Procedures, Surgical Procedures, Therapeutic Procedures), By End-Use (Hospitals, Clinics, Research Institutes, Diagnostic Centers), and By Region; Global Insights & Forecast (2023 – 2030).

As per Intent Market Research, the Gastroenterology Market was valued at USD 74.0 Billion in 2024-e and will surpass USD 117.2 Billion by 2030; growing at a CAGR of 8.0% during 2025-2030.

The global gastroenterology market is seeing significant growth driven by an increasing prevalence of gastrointestinal (GI) disorders and technological advancements in medical treatments and diagnostic devices. The rising demand for minimally invasive procedures, such as endoscopy and laparoscopic surgery, has led to a surge in the development of new tools and treatments. Additionally, biologics and other advanced therapies for conditions like inflammatory bowel disease (IBD) are expanding, further driving the market’s growth. The continuous rise in healthcare investments, technological innovations, and the growing awareness of digestive diseases also contribute to the market’s positive outlook.

Endoscopy Devices Market Is Largest Owing to Growing Diagnostic Demand

Endoscopy devices have become the largest segment in the gastroenterology market, owing to their widespread usage in diagnosing and treating gastrointestinal diseases. These devices allow for minimally invasive procedures, which are preferred by both healthcare professionals and patients due to shorter recovery times and reduced risks of complications. Endoscopy is particularly important for diagnosing colorectal cancer, IBD, and GERD, as it enables direct visualization of the GI tract. Furthermore, advancements in endoscopic imaging, such as high-definition and 3D imaging, are improving the accuracy and efficacy of diagnoses, thereby increasing their adoption.

Endoscopy devices are also critical in therapeutic procedures, such as the removal of polyps or biopsies, and their demand is further spurred by the increasing awareness of preventive healthcare. With the rise of colorectal cancer and IBD, these devices have become indispensable tools in early detection and management, helping healthcare systems reduce the burden of advanced-stage diseases and associated costs. Given the increasing preference for non-invasive options, endoscopy devices will continue to dominate the gastroenterology market in the coming years.

Colorectal Cancer Segment Is Fastest Growing Owing to Rising Incidence Rates

Among various disease types in the gastroenterology market, colorectal cancer is the fastest-growing segment, largely driven by the increasing incidence rates across the globe. Factors such as aging populations, lifestyle changes, unhealthy dietary habits, and a lack of physical activity have contributed to a rise in colorectal cancer cases, especially in developed countries. Early detection through screening and diagnostic tools like colonoscopy and endoscopy is crucial, and advancements in these areas are significantly driving the growth of the colorectal cancer segment.

The increasing awareness of the importance of early screening and genetic testing has prompted individuals to seek out diagnostic options more frequently, further fueling this segment's growth. Additionally, the development of biologics and targeted therapies for colorectal cancer has broadened treatment options, providing new hope for patients and healthcare professionals alike. Given the ongoing efforts to improve colorectal cancer detection, treatment, and prevention, this segment is expected to continue its robust growth in the near future.

Diagnostic Procedures Segment Is Largest Owing to Increased Demand for Early Detection

Diagnostic procedures represent the largest subsegment under procedure types in the gastroenterology market. The rising prevalence of gastrointestinal diseases such as GERD, IBD, and colorectal cancer has led to an increased demand for early diagnosis and screening. As a result, diagnostic procedures are crucial for identifying underlying conditions at an early stage, allowing for better management and treatment outcomes. These procedures include endoscopy, colonoscopy, imaging, and biopsy, all of which are integral parts of modern gastroenterology practice.

The growing demand for diagnostic procedures can also be attributed to the increasing awareness of gastrointestinal diseases, along with government initiatives promoting preventive healthcare. Moreover, advancements in imaging technologies, such as high-resolution endoscopes and AI-assisted diagnostic tools, have further enhanced the accuracy and efficiency of diagnostic procedures. With early detection being pivotal to effective treatment, the diagnostic procedure segment will continue to be the largest in the gastroenterology market.

Hospitals Segment Is Largest End-User Due to Comprehensive Care Delivery

Hospitals are the largest end-user segment in the gastroenterology market, owing to their ability to offer a wide range of services for both diagnostics and treatment. Hospitals provide a one-stop solution for patients seeking care for GI disorders, offering diagnostic imaging, therapeutic procedures, and post-operative care all in one setting. The presence of specialized gastroenterology departments and multidisciplinary teams ensures comprehensive management of diseases like colorectal cancer, GERD, and IBD.

The increasing number of hospital admissions due to GI-related issues and the growing healthcare infrastructure in emerging markets have bolstered the demand for gastroenterology services. Hospitals also benefit from advances in medical technologies, allowing them to provide cutting-edge treatments and ensure higher patient outcomes. As such, hospitals will continue to dominate the gastroenterology end-user market.

North America Is Largest Region Owing to Advanced Healthcare Systems

North America is the largest region in the gastroenterology market, driven by the region's advanced healthcare infrastructure and the rising prevalence of gastrointestinal disorders. The U.S. and Canada have well-established healthcare systems that offer advanced diagnostic and therapeutic options, including the latest endoscopy devices and biologics. Additionally, the region is home to many leading companies in the gastroenterology field, contributing to its dominance in both production and innovation.

The growing awareness of gastrointestinal diseases, combined with favorable reimbursement policies and access to state-of-the-art healthcare services, further supports the market in this region. Moreover, North America’s aging population, coupled with lifestyle changes, is expected to continue fueling the demand for gastroenterology solutions in the coming years, further cementing its position as the largest region in the global market.

Leading Companies and Competitive Landscape

The global gastroenterology market is highly competitive, with several key players actively participating in product development, partnerships, and acquisitions. Medtronic, Johnson & Johnson, Boston Scientific, and Olympus Corporation are some of the leading companies in the market, known for their innovative endoscopy devices, diagnostic imaging systems, and treatment options. These companies have been at the forefront of advancing minimally invasive procedures and developing biologic therapies for gastrointestinal diseases.

To maintain their competitive edge, these companies are focusing on expanding their product portfolios and integrating new technologies like AI and robotic surgery. Strategic collaborations, acquisitions, and research partnerships are common in the market, as companies aim to enhance their market share and product offerings. Furthermore, regulatory approvals and compliance with industry standards play a crucial role in the competitive dynamics of the market, making innovation and regulatory expertise essential for sustaining growth.

List of Leading Companies:

• Medtronic Plc
• Johnson & Johnson
• Boston Scientific Corporation
• Abbott Laboratories
• Stryker Corporation
• Olympus Corporation
• Thermo Fisher Scientific Inc.
• Cook Medical
• ConMed Corporation
• Pentax Medical (Hoya Corporation)
• Intuitive Surgical, Inc.
• Siemens Healthineers
• Fujifilm Holdings Corporation
• General Electric Company
• B. Braun Melsungen AG

Recent Developments:

• Medtronic announced the launch of its new minimally invasive surgical instruments for gastroenterology, aimed at enhancing precision and reducing recovery time for patients.
• Boston Scientific received regulatory approval for its new endoscopy system, which provides enhanced imaging and accuracy for colorectal cancer diagnosis.
• Johnson & Johnson entered into a strategic partnership with a biotech firm to co-develop biologic therapies for inflammatory bowel disease (IBD), enhancing its treatment portfolio.
• Olympus Corporation introduced its latest advanced endoscopy equipment, designed for real-time diagnostic imaging in gastrointestinal procedures, improving patient outcomes.
• Fujifilm expanded its presence in the gastroenterology market through the acquisition of a leading endoscopic technology provider, enhancing its product offerings in diagnostic imaging.

Report Scope: